🔺 What to do when markets are at an all-time high? Find smart bargains, like these.See Undervalued Stocks

ABVC Biopharma Inc (ABVC)

NASDAQ
Currency in USD
0.4411
-0.0356(-7.47%)
Real-time Data
ABVC Scorecard
Full Analysis
Quickly burning through cash
Unusual trading volume
Fair Value
Day's Range
0.42360.4561
52 wk Range
0.40532.4500
Key Statistics
Edit
Prev. Close
0.4747
Open
0.45
Day's Range
0.4236-0.4561
52 wk Range
0.4053-2.45
Volume
4.71M
Average Volume (3m)
150.66K
1-Year Change
-54.79%
Book Value / Share
0.7
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ABVC Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Stock has taken a big hit over the last week
Show more

ABVC Biopharma Company Profile

ABVC BioPharma, Inc., a clinical stage biopharmaceutical company, develops drugs and medical devices to fulfill unmet medical needs in the United States. The company is developing ABV-1501, which is in Phase II clinical trials a combination therapy for triple negative breast cancer; ABV-1504 has completed Phase II clinical trials for major depressive disorders; ABV-1505, which is in Phase II clinical trials for adult attention deficit hyperactivity disorder; ABV-1703, which is in Phase II clinical trials for the treatment of metastatic pancreatic cancer; ABV-1702, which is in Phase II clinical trials to treat myelodysplastic syndromes; and ABV-1601 that is in Phase I/II clinical trials for treating depression in cancer patients. It is also developing ABV-1701 Vitargus that is in Phase II clinical trials for the treatment of retinal detachment or vitreous hemorrhage; and ABV-1519, which is in Phase I/II clinical trials for the treatment of non-small cell lung cancer. ABVC BioPharma, Inc. has a co-development agreement with Rgene Corporation; and collaboration agreements with BioHopeKing Corporation and BioFirst Corporation. The company is based in Fremont, California. ABVC BioPharma, Inc. operates as a subsidiary of YuanGene Corporation.

Compare ABVC to Peers and Sector

Metrics to compare
ABVC
Peers
Sector
Relationship
P/E Ratio
−0.7x−1.1x−0.7x
PEG Ratio
−0.010.000.00
Price/Book
0.7x2.5x2.6x
Price / LTM Sales
12.0x14.5x3.2x
Upside (Analyst Target)
-70.0%47.1%
Fair Value Upside
Unlock30.8%7.3%Unlock

FAQ

What Is the ABVC Biopharma (ABVC) Stock Price Today?

The ABVC Biopharma stock price today is 0.4411.

What Stock Exchange Does ABVC Biopharma Trade On?

ABVC Biopharma is listed and trades on the NASDAQ stock exchange.

What Is the Stock Symbol for ABVC Biopharma?

The stock symbol for ABVC Biopharma is "ABVC."

What Is the ABVC Biopharma Market Cap?

As of today, ABVC Biopharma market cap is 6.13M.

What is ABVC Biopharma Earnings Per Share?

The ABVC Biopharma EPS is -0.821.

From a Technical Analysis Perspective, Is ABVC a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.